EuBiologics Co. Ltd.

EuBiologics Co., Ltd. is a biopharmaceutical company based in Seoul, South Korea, focused on developing vaccines against global pandemics and bacterial vaccines. Its products include the inactivated oral cholera vaccine sold under the Euvichol, Euvichol-Plus, and Euvichol-S names, and EuCorVac-19, a recombinant protein vaccine. The company also offers EcML, a vaccine adjuvant that directly activates antigen-presenting cells expressing TLR 4 agonist and stimulates the production of cytokines and co-stimulatory molecules, as well as a carrier protein vaccine under the rCRM197 name. In addition, it provides biopharmaceutical contract research, manufacturing, and contract testing services, and supports the development of biomedicine manufacturing technologies. The company was founded in 2010.